Tian, L., Zhao, M., Hu, Y., Wang, K., Liu, H., Bai, Z., & Zheng, K. (2026). Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma. Annals of Clinical & Translational Neurology, 1. https://doi.org/10.1002/acn3.70481
Chicago Style (17th ed.) CitationTian, Langfei, Minghui Zhao, Yuanbo Hu, Kaiyue Wang, Haiguang Liu, Zetong Bai, and Kebin Zheng. "Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma." Annals of Clinical & Translational Neurology 2026: 1. https://doi.org/10.1002/acn3.70481.
MLA (9th ed.) CitationTian, Langfei, et al. "Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma." Annals of Clinical & Translational Neurology, 2026, p. 1, https://doi.org/10.1002/acn3.70481.